[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

October 2017 - July 1883

Decade

Year

Issue

August 15, 2017, Vol 318, No. 7, Pages 587-676

In This Issue of JAMA

Highlights

Abstract Full Text
free access has audio
JAMA. 2017;318(7):587-589. doi:10.1001/jama.2016.13267
Viewpoint

Consideration of Dental, Vision, and Hearing Services to Be Covered Under Medicare

Abstract Full Text
JAMA. 2017;318(7):605-606. doi:10.1001/jama.2017.8647

This Viewpoint argues that Medicare coverage should be expanded to include dental, vision, and hearing services, and discusses ways to structure the benefit.

Diagnostic Stewardship—Leveraging the Laboratory to Improve Antimicrobial Use

Abstract Full Text
JAMA. 2017;318(7):607-608. doi:10.1001/jama.2017.8531

This Viewpoint discusses the potential benefits and harms of diagnostic stewardship—modifying the ordering, performance, and reporting of diagnostic tests to improve treatment—as a means of reducing inappropriate antibiotic use.

Value-Based Pricing and State Reform of Prescription Drug Costs

Abstract Full Text
JAMA. 2017;318(7):609-610. doi:10.1001/jama.2017.8255

This Viewpoint discusses a New York law that allows the state to negotiate rebates with manufacturers to obtain value-based prices for drugs in its Medicaid program and assesses the potential effects of value-based pricing.

A Piece of My Mind

Climate ChangeWhat Would Lincoln Do?

Abstract Full Text
JAMA. 2017;318(7):611. doi:10.1001/jama.2017.6999

Trials and Tribulations

Abstract Full Text
JAMA. 2017;318(7):612-613. doi:10.1001/jama.2017.7106
Editorial

Balancing the Need for Access With the Imperative for Empirical Evidence of Benefit and Risk

Abstract Full Text
has audio
JAMA. 2017;318(7):614-616. doi:10.1001/jama.2017.9412

Shared Decision Making and Improving Health CareThe Answer Is Not In

Abstract Full Text
JAMA. 2017;318(7):617-618. doi:10.1001/jama.2017.10168
Original Investigation

Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements

Abstract Full Text
has active quiz has audio
JAMA. 2017;318(7):619-625. doi:10.1001/jama.2017.9414

This study characterizes the quality of clinical studies and data used to support US Food and Drug Administration approval of modifications to high-risk medical devices.

Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration

Abstract Full Text
has active quiz has audio
JAMA. 2017;318(7):626-636. doi:10.1001/jama.2017.9415

This study uses public US Food and Drug Administration (FDA) data to characterize drug trials used to obtain FDA accelerated approval and to describe the existence, timing, and characteristics of postapproval trials mandated by the FDA as part of the accelerated approval decision.

Preliminary Communication

Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 DiabetesA Randomized Clinical Trial

Abstract Full Text
JAMA. 2017;318(7):637-646. doi:10.1001/jama.2017.10169

This randomized clinical trial compared the effects of an intensive lifestyle intervention vs standard care on glycemic control and medication reduction among participants with non–insulin-dependent type 2 diabetes.

Review

Celiac Disease and Nonceliac Gluten SensitivityA Review

Abstract Full Text
has active quiz
JAMA. 2017;318(7):647-656. doi:10.1001/jama.2017.9730

This review discusses the the role of a gluten-free diet in the clinical management of celiac disease and nonceliac gluten sensitivity and highlights the importance for long-term therapy of distinguishing between these conditions.

JAMA Clinical Evidence Synopsis

Patient Decision Aids to Engage Adults in Treatment or Screening Decisions

Abstract Full Text
JAMA. 2017;318(7):657-658. doi:10.1001/jama.2017.10289

This Clinical Evidence Synopsis summarizes a Cochrane review of clinical trials evaluating patient decision aids designed to help patients understand their treatment options.

From The Medical Letter on Drugs and Therapeutics

Bezlotoxumab (Zinplava) for Prevention of Recurrent Clostridium Difficile Infection

Abstract Full Text
JAMA. 2017;318(7):659-660. doi:10.1001/jama.2017.10092

This Medical Letter review summarizes the indications, risks, and benefits of bezlotoxumab, a monoclonal antibody to be used with antibacterial drug treatment to reduce recurrence of Clostridium difficile infection in adults at high risk.

Research Letter

Public Response to a Proposed Field Trial of Genetically Engineered Mosquitoes in the United States

Abstract Full Text
JAMA. 2017;318(7):662-664. doi:10.1001/jama.2017.9285

This study assesses public response to a proposed field trial in the United States of genetically engineered mosquito (OX513A) designed to suppress wild-type Aedes aegypti mosquitoes, which can transmit diseases such as Zika, dengue, and chikungunya.

Comment & Response

Prenatal Antidepressant Use and Autism Spectrum Disorder

Abstract Full Text
JAMA. 2017;318(7):664-665. doi:10.1001/jama.2017.8640

Prenatal Antidepressant Use and Autism Spectrum Disorder—Reply

Abstract Full Text
JAMA. 2017;318(7):665. doi:10.1001/jama.2017.8643

Maternal Antidepressant Use and Pregnancy Outcomes

Abstract Full Text
JAMA. 2017;318(7):665-666. doi:10.1001/jama.2017.9182

Maternal Antidepressant Use and Pregnancy Outcomes

Abstract Full Text
JAMA. 2017;318(7):666-667. doi:10.1001/jama.2017.9194

Alveolar Recruitment Strategies After Cardiac Surgery

Abstract Full Text
JAMA. 2017;318(7):667. doi:10.1001/jama.2017.8689

Alveolar Recruitment Strategies After Cardiac Surgery

Abstract Full Text
JAMA. 2017;318(7):667-668. doi:10.1001/jama.2017.8693

Alveolar Recruitment Strategies After Cardiac Surgery—Reply

Abstract Full Text
JAMA. 2017;318(7):668-669. doi:10.1001/jama.2017.8697
Correction

Incomplete Financial Disclosure

Abstract Full Text
free access
JAMA. 2017;318(7):669. doi:10.1001/jama.2017.10520
Medical News & Perspectives

Half-century After “Summer of Love,” Free Clinics Still Play Vital Role

Abstract Full Text
JAMA. 2017;318(7):598-600. doi:10.1001/jama.2017.8631

This Medical News story discusses the founding of the first free clinics in the United States and the role free clinics continue to play in communities across the country.

The JAMA Forum

Reforming Medicaid

Abstract Full Text
free access
JAMA. 2017;318(7):601-602. doi:10.1001/jama.2017.10341
Global Health

Lethal Heat Waves Expected to Increase

Abstract Full Text
JAMA. 2017;318(7):603. doi:10.1001/jama.2017.10120

Effect of Malaria Initiative

Abstract Full Text
JAMA. 2017;318(7):603. doi:10.1001/jama.2017.10691

Global Obesity Epidemic Worsening

Abstract Full Text
JAMA. 2017;318(7):603. doi:10.1001/jama.2017.10693
News From the Food and Drug Administration

Faster Orphan Drug Decisions

Abstract Full Text
JAMA. 2017;318(7):604. doi:10.1001/jama.2017.10130

Sickle Cell Therapy Drought Ends

Abstract Full Text
JAMA. 2017;318(7):604. doi:10.1001/jama.2017.10152

New Leukemia, Lymphoma Diagnostic

Abstract Full Text
JAMA. 2017;318(7):604. doi:10.1001/jama.2017.10283
Poetry and Medicine

A Song of Hope

Abstract Full Text
JAMA. 2017;318(7):671. doi:10.1001/jama.2017.2871
JAMA Revisited

Politics and the Medical Profession

Abstract Full Text
JAMA. 2017;318(7):672. doi:10.1001/jama.2017.9011
JAMA Patient Page

Eye Emergencies

Abstract Full Text
free access
JAMA. 2017;318(7):676. doi:10.1001/jama.2017.9899
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2017;318(7):591-592. doi:10.1001/jama.2016.13268
×